Profile
Eric Baclet currently works at Genfit SA, as Vice Chairman from 2024 and Amanys Pharma, as Director.
Mr. Baclet also formerly worked at Future Pharmaceutical Industries, as Director and Eli Lilly Italia SpA, as President & General Manager.
Mr. Baclet received his undergraduate degree from Universite Paris Cite.
Eric Baclet active positions
| Companies | Position | Start |
|---|---|---|
| GENFIT | Director/Board Member | 07/07/2020 |
Amanys Pharma
Amanys Pharma Pharmaceuticals: GenericHealth Technology Manufactures antibiotics and hospital specialty drugs | Director/Board Member | - |
Former positions of Eric Baclet
| Companies | Position | End |
|---|---|---|
Future Pharmaceutical Industries
Future Pharmaceutical Industries Pharmaceuticals: MajorHealth Technology Manufactures and produces pharmaceutical substances | Director/Board Member | - |
Eli Lilly Italia SpA
Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | President | - |
Training of Eric Baclet
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genfit SA
Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
Eli Lilly Italia SpA
Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Future Pharmaceutical Industries
Future Pharmaceutical Industries Pharmaceuticals: MajorHealth Technology Manufactures and produces pharmaceutical substances | Health Technology |
Amanys Pharma
Amanys Pharma Pharmaceuticals: GenericHealth Technology Manufactures antibiotics and hospital specialty drugs | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Eric Baclet
















